Cargando…
Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53
Despite considerable progress, the treatment of acute leukemia continues to be a challenge for a significant majority of patients. Using a well-characterized preclinical mouse model of acute promyelocytic leukemia (APL), we evaluated here the antileukemic efficacy of RT53, an anticancer peptide with...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051191/ https://www.ncbi.nlm.nih.gov/pubmed/32158621 http://dx.doi.org/10.1080/2162402X.2020.1728871 |